InChI=1S/C54H82O4/c1- 40(2) 22- 14- 23- 41(3) 24- 15- 25- 42(4) 26- 16- 27- 43(5) 28- 17- 29- 44(6) 30- 18- 31- 45(7) 32- 19- 33- 46(8) 34- 20- 35- 47(9) 36- 21- 37- 48(10) 38- 39- 50- 49(11) 51(55) 53(57- 12) 54(58- 13) 52(50) 56/h22,24,26,28,30,32,34,36,38H,14- 21,23,25,27,29,31,33,35,37,39H2,1- 13H3/b41- 24+,42- 26+,43- 28+,44- 30+,45- 32+,46- 34+,47- 36+,48- 38+ |
UUGXJSBPSRROMU-WJNLUYJISA-N |
COC1=C(OC) C(=O) C(C\C=C(/C) CC\C=C(/C) CC\C=C(/C) CC\C=C(/C) CC\C=C(/C) CC\C=C(/C) CC\C=C(/C) CC\C=C(/C) CCC=C(C) C) =C(C) C1=O |
|
antioxidant
A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
|
|
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
Escherichia coli metabolite
Any bacterial metabolite produced during a metabolic reaction in Escherichia coli.
(via ubiquinones )
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
(via ubiquinones )
|
|
View more via ChEBI Ontology
2,3- dimethoxy- 5- methyl- 6- [(2E,6E,10E,14E,18E,22E,26E,30E)- 3,7,11,15,19,23,27,31,35- nonamethylhexatriaconta- 2,6,10,14,18,22,26,30,34- nonaen- 1- yl]cyclohexa- 2,5- diene- 1,4- dione
|
(all- E)- 2,3- dimethoxy- 5- methyl- 6- (3,7,11,15,19,23,27,31,35- nonamethyl- 2,6,10,14,18,22,26,30,34- hexatriacontanonaenyl)- 2,5- cyclohexadiene- 1,4- dione
|
ChemIDplus
|
2,3- dimethoxy- 5- methyl- 6- [(2E,6E,10E,14E,18E,22E,26E,30E)- 3,7,11,15,19,23,27,31,35- nonamethylhexatriaconta- 2,6,10,14,18,22,26,30,34- nonaen- 1- yl]- 1,4- benzoquinone
|
ChEBI
|
coenzyme Q9
|
ChemIDplus
|
CoQ9
|
ChemIDplus
|
Ubiquinone-45
|
KEGG COMPOUND
|
Ubiquinone-9
|
KEGG COMPOUND
|
ubiquinone-9
|
UniProt
|
1900081
|
Beilstein Registry Number
|
ChemIDplus
|
303-97-9
|
CAS Registry Number
|
ChemIDplus
|
12853115
|
PubMed citation
|
Europe PMC
|
|